Core Viewpoint - The establishment of the Regenerative Medicine Clinical Research Center at Hunan University aims to integrate industry, academia, and research to drive innovation in the field of regenerative medicine, focusing on major disease diagnosis and treatment, as well as organ damage repair [1][2]. Group 1: Center Establishment and Objectives - The center is a collaboration involving Hunan University, Hunan Provincial Tumor Hospital, and several other medical institutions, designed to promote a new path for the integration of research and industry [1]. - The center will leverage clinical needs to guide research and innovation, aiming to create a closed loop from basic research to clinical application and industrial transformation [2]. Group 2: Industry Context and Market Potential - The global cell therapy market has surpassed $400 billion, indicating significant growth potential in the regenerative medicine sector [2]. - Hunan Province is working to develop a trillion-level stem cell and regenerative medicine industry chain, with a focus on innovation and collaboration among various stakeholders [2]. Group 3: Strategic Contributions and Infrastructure - Dajia Weikang, as a co-builder of the center, will invest in technology, talent, and funding to accelerate the transition of cutting-edge therapies from the lab to clinical practice [1]. - The center will establish a cell seed bank and regenerative medicine product library, aiming to create an internationally competitive application testing center for stem cells and regenerative medicine products [2].
湖南大学再生医学临床研究中心成立 达嘉维康加码再生医学